Solve complex formulation challenges with the next generation of direct compression
Superior compactability for high dosage
Compressol™ ProTab is a multifunctional soluble excipient platform designed for direct compression. It remains effective even with potent, sensitive, or fragile actives, delivering consistent performance, stability, and manufacturability across a wide range of tablet formats.
This low moisture binder, allows tablets to be made at low compaction and still retain the function of sensitive active ingredients like probiotics and multi-unit particle systems (MUPS).
Additional benefits of Compressol™ ProTab:
Learn more about the next generation of direct compression?
How Compressol ProTab excels in the industry
High-Does Actives & Formulation Ease
Probiotic Viability
• Exceptionally low water activity
chewables & ODTs
Controlled Release & MUPS Compatibility
Versatility
Compressol ProTab Applications include:
✔️ Tableting of difficult to compress pharmaceutical active ingredients
✔️ Less excipient used, reducing tablet size
Compressol™ ProTab is an effective solution for the following applications:
Application Examples:
Directly Compressible (DC) Tablets
DC tableting is often the top choice in making dosage forms but can be difficult with certain actives, requiring additional binding agents, leading to larger tablets, or requiring using alternate technologies, or use of capsule delivery. Moisture sensitive actives create additional challenges.
KEY BENEFITS
• Produces tablets with low compressibility actives
• Compresses high dose formulations
• A low moisture choice for sensitive actives
• Use with poor flow or low-density actives
Probiotic Tablets
Probiotic strains like Saccharomyces cerevisiae (boulardii) and Lactobacillus acidophilus are highly sensitive to processing conditions. Using low compression forces in tableting helps preserve cell viability.
KEY BENEFITS
• Maintains probiotic viability in tablets
• Reduces required starting load of probiotic cultures
• Cost savings for manufacturers and final dosage forms
• Enables differentiated probiotic delivery formats
Pellet-Based Drug Delivery
KEY BENEFITS
• Ensures coating integrity of coated pellets in MUPS tablets ex. Masking & Modified Release
• Produces MUPS tablets of higher tensile strength at low compression force with low friability
• Improved consistency of drug release in controlled-release tablets
• Reduced risk of dose dumping
Chewable Tablets
KEY BENEFITS
• Reduced tablet weight without sacrificing strength
• Sugar-free and lactose-free formulation options
• Enables higher-dose single tablets
• Easy-to-chew tablets, even at higher weights (up to 2,500 mg)
• Allows single-tablet daily dose, eliminating the need for multiple capsules
Compressol™ ProTab excels where traditional excipients fall short.
Our team is ready to help you solve complex formulation challenges with the next generation of direct compression SPI's Compressol™ ProTab. Click on the button below, or contact us if you are interested in learning more.